The European Commission has approved an indication extension for Johnson & Johnson's Tecvayli (teclistamab) as monotherapy ...
US pharma major Bristol Myers Squibb and SystImmune, the US biotech, said the Phase III PANKU-Breast01 trial of izalontamab ...
Germany-headquartered CNS drug specialist Neuraxpharm Group today announced the presentation of new scientific data on Briumvi (ublituximab) at the 10th Joint ACTRIMS-ECTRIMS Meeting, also referred to ...
Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely ...
Shares in UCB, the Belgian biopharma company, closed 21.6% higher at 259.10 euros on Thursday after it raised its 2026 ...
Danish drugmaker Novo (NOV: N) and US pharma major Eli Lilly (NYSE: LLY) are competing across a widening range of obesity ...
Zymeworks, the Vancouver-based biotech, has signed an exclusive global license and collaboration agreement with Roche for ...
US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...
Pharmaceutical companies’ reliance on Chinese suppliers extends from early laboratory work to the production of medicines for ...
US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...
The US Treasury Department has proposed adding biotech to the sectors covered by its outbound investment rules, a move that ...
Danish clinical-stage techbio Evaxion has announced new three-year immune and clinical outcome data for personalized cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results